Skip to search formSkip to main contentSkip to account menu

response to doxorubicin

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Response to Doxorubicin of Exfoliated Human Buccal Epithelium Cells: Comparison of Three Methods of Cell Staining and Calcium Assessment.
BACKGROUND Doxorubicin is an anthracycline antibiotic which inhibits DNA and RNA synthesis intercalating DNA double helix and… 
2016
2016
Evaluating the Role of TGFbeta and its Downstream Signaling Mediator TAZ in Canine Osteosarcoma Response to Doxorubicin
EVALUATING THE ROLE OF TGFΒETA AND ITS DOWNSTREAM SIGNALING MEDIATOR TAZ IN CANINE OSTEOSARCOMA RESPONSE TO DOXORUBICIN Adam… 
2014
2014
Maspin influences response to doxorubicin by changing the tumor microenvironment organization
Altered degradation and deposition of extracellular matrix are hallmarks of tumor progression and response to therapy. From a… 
Review
2013
Review
2013
Dramatic and Delayed Response to Doxorubicin-Dacarbazine Chemotherapy of a Giant Desmoid Tumor: Case Report and Literature Review
Desmoid tumors are benign, slow-growing mesenchymal tumors. Aggressiveness is local with no potential for metastasis or… 
2012
2012
RAC1 SIGNALLING MEDIATES DOXORUBICIN-INDUCED CARDIOTOXICITY THROUGH BOTH REACTIVE OXYGEN SPECIES DEPENDENT AND INDEPENDENT PATHWAYS
Objectives Doxorubicin causes damage to the heart, often leading to irreversible cardiomyopathy, which is fatal. Reactive oxygen… 
2012
2012
270 The NF-kappa B Signalling Pathway and the Response to Doxorubicin in Hormone-resistant Breast Cancer Cells
2009
2009
Expression of Gene Trios as Predictive Markers of Response to Doxorubicin Based Primary Chemotherapy in Breast Cancer Patients.
Some studies have been carried out to identify a gene expression profile predictive of drug response in breast cancer patients… 
2005
2005
POLYMORPHISMS IN THE ABCB1 AND THE GST GENES IN RELATION TO P53 MUTATION AND TREATMENT RESPONSE TO DOXORUBICIN IN BREAST CANCER PATIENTS
2003
2003
In vitro Study of the p53 Pathway in Peripheral Blood Mononuclear Cells in Response to Doxorubicin Treatment
2000
2000
Commentary on “A Study of the Value of p53, HER2, and Bcl-2 in the Prediction of Response to Doxorubicin and Paclitaxel as Single Agents in Metastatic Breast Cancer: A Companion Study to EORTC 10923”
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)